UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 76

Sortiert nach

Prognostic factors in epithelial ovarian cancer: A population-based study

PloS one, 2018-03, Vol.13 (3), p.e0194993

2018

Link zum Volltext

Verfügbarkeit prüfen

Investigation of Immunogenicity Assessment of Biosimilar Monoclonal Antibodies in the United States

Clinical pharmacology and therapeutics, 2023-12, Vol.114 (6), p.1274-1284

2023

Link zum Volltext

Verfügbarkeit prüfen

Investigation of Factors Associated With Immunogenicity Labeling Updates and Characteristics of Biologics License Applications

Clinical pharmacology and therapeutics, 2021-11, Vol.110 (5), p.1381-1388

2021

Link zum Volltext

Verfügbarkeit prüfen

The biosimilar pathway in the USA: An analysis of the innovator company and biosimilar company perspectives and beyond

Journal of food and drug analysis, 2019-07, Vol.27 (3), p.671-678

Chang, Lin-Chau

2019

Link zum Volltext

Verfügbarkeit prüfen

Patterns of use and impact of standardised MedDRA query analyses on the safety evaluation and review of new drug and biologics license applications

PloS one, 2017-06, Vol.12 (6), p.e0178104-e0178104

2017

Link zum Volltext

Verfügbarkeit prüfen

Cell metabolomics analyses revealed a role of altered fatty acid oxidation in neurotoxicity pattern difference between nab-paclitaxel and solvent-based paclitaxel

PloS one, 2021-03, Vol.16 (3), p.e0248942

2021

Link zum Volltext

Verfügbarkeit prüfen

Evaluation and Optimization of Sample Handling Methods for Quantification of Short-Chain Fatty Acids in Human Fecal Samples by GC–MS

Journal of proteome research, 2019-05, Vol.18 (5), p.1948-1957

2019

Link zum Volltext

Verfügbarkeit prüfen

Interfacial properties of Pluronics and the interactions between Pluronics and cholesterol/DPPC mixed monolayers

Journal of colloid and interface science, 2008-06, Vol.322 (1), p.263-273

2008

Link zum Volltext

Verfügbarkeit prüfen

Curcumin-derived carbon quantum dots: Dual actions in mitigating tau hyperphosphorylation and amyloid beta aggregation

Colloids and surfaces, B, Biointerfaces, 2024-02, Vol.234, p.113676-113676, Article 113676

2024

Link zum Volltext

Verfügbarkeit prüfen

Differences in Fatty Acid Oxidation between Nab-Paclitaxel- and Solvent-Based Paclitaxel-Treated A549 Cells Based on Metabolomics

ACS omega, 2021-03, Vol.6 (8), p.5138-5145

2021

Link zum Volltext

Verfügbarkeit prüfen

Orphan drug development: The impact of regulatory and reimbursement frameworks

Drug discovery today, 2022-06, Vol.27 (6), p.1724-1732

2022

Link zum Volltext

Verfügbarkeit prüfen

Correlates of time to approval and other clinical development periods

Drug discovery today, 2019-09, Vol.24 (9), p.1871-1876

2019

Link zum Volltext

Verfügbarkeit prüfen

Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond

Journal of biomedical science, 2008-09, Vol.15 (5), p.565-576

2008

Link zum Volltext

Verfügbarkeit prüfen

Identification of factors associated with first-cycle drug approval rates and regulatory outcomes for new drug applications

Pharmacological research, 2019-01, Vol.139, p.166-172

2019

Link zum Volltext

Verfügbarkeit prüfen

Improved Dried Blood Spot-Based Metabolomics Analysis by a Postcolumn Infused-Internal Standard Assisted Liquid Chromatography-Electrospray Ionization Mass Spectrometry Method

Analytical chemistry (Washington), 2019-08, Vol.91 (16), p.10702-10712

2019

Link zum Volltext

Verfügbarkeit prüfen

Investigation of quality review issues and the association with application characteristics for new drug applications in first-cycle reviews

Regulatory toxicology and pharmacology, 2019-11, Vol.108, p.104448, Article 104448

2019

Link zum Volltext

Verfügbarkeit prüfen

Enhancing the identification of voriconazole-associated hepatotoxicity by targeted metabolomics

International journal of antimicrobial agents, 2024-01, Vol.63 (1), p.107028-107028, Article 107028

2024

Link zum Volltext

Verfügbarkeit prüfen

Recent updates and challenges on the regulation of precision medicine: The United States in perspective

Regulatory toxicology and pharmacology, 2018-07, Vol.96, p.41-47

2018

Link zum Volltext

Verfügbarkeit prüfen

The Clinical Implications of Blood Adiponectin in Cardiometabolic Disorders

Journal of the Formosan Medical Association, 2009-05, Vol.108 (5), p.353-366

2009

Link zum Volltext

Verfügbarkeit prüfen

Regulatory considerations for generic products of non-biological complex drugs

Journal of food and drug analysis, 2023-03, Vol.31 (1), p.20-31

2023

Link zum Volltext

Verfügbarkeit prüfen

Determining Estrogens Using Surface-Assisted Laser Desorption/Ionization Mass Spectrometry with Silver Nanoparticles as the Matrix

Journal of the American Society for Mass Spectrometry, 2008-09, Vol.19 (9), p.1343-1346

2008

Link zum Volltext

Verfügbarkeit prüfen

The impact of the rare disease and Orphan Drug Act in Taiwan

Journal of food and drug analysis, 2021-12, Vol.29 (4), p.717-725

2021

Link zum Volltext

Verfügbarkeit prüfen

Development of the risk-based, phased-in approach for the international harmonization of the regulation of container closure systems for drugs in Taiwan

Regulatory toxicology and pharmacology, 2016-06, Vol.77, p.252-256

2016

Link zum Volltext

Verfügbarkeit prüfen

The evolution and challenges for the international harmonization of the regulation of pharmaceutical excipients in Taiwan

Regulatory toxicology and pharmacology, 2015-12, Vol.73 (3), p.947-952

2015

Link zum Volltext

Verfügbarkeit prüfen

Thyrotropin receptor antibodies and a genetic hint in antithyroid drug-induced adverse drug reactions

Expert opinion on drug safety, 2018-08, Vol.17 (8), p.775-784

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 76

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(73)

Publikationsform

Artikel
(72)
Tagungsberichte
(4)

Sprache

Englisch
(76)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prognostic factors in epithelial ovarian cancer: A population-based study

Investigation of Immunogenicity Assessment of Biosimilar Monoclonal Antibodies in the United States

Investigation of Factors Associated With Immunogenicity Labeling Updates and Characteristics of Biologics License Applications

The biosimilar pathway in the USA: An analysis of the innovator company and biosimilar company perspectives and beyond

Patterns of use and impact of standardised MedDRA query analyses on the safety evaluation and review of new drug and biologics license applications

Cell metabolomics analyses revealed a role of altered fatty acid oxidation in neurotoxicity pattern difference between nab-paclitaxel and solvent-based paclitaxel

Evaluation and Optimization of Sample Handling Methods for Quantification of Short-Chain Fatty Acids in Human Fecal Samples by GC–MS

Interfacial properties of Pluronics and the interactions between Pluronics and cholesterol/DPPC mixed monolayers

Curcumin-derived carbon quantum dots: Dual actions in mitigating tau hyperphosphorylation and amyloid beta aggregation

Differences in Fatty Acid Oxidation between Nab-Paclitaxel- and Solvent-Based Paclitaxel-Treated A549 Cells Based on Metabolomics

Orphan drug development: The impact of regulatory and reimbursement frameworks

Correlates of time to approval and other clinical development periods

Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond

Identification of factors associated with first-cycle drug approval rates and regulatory outcomes for new drug applications

Improved Dried Blood Spot-Based Metabolomics Analysis by a Postcolumn Infused-Internal Standard Assisted Liquid Chromatography-Electrospray Ionization Mass Spectrometry Method

Investigation of quality review issues and the association with application characteristics for new drug applications in first-cycle reviews

Enhancing the identification of voriconazole-associated hepatotoxicity by targeted metabolomics

Recent updates and challenges on the regulation of precision medicine: The United States in perspective

The Clinical Implications of Blood Adiponectin in Cardiometabolic Disorders

Regulatory considerations for generic products of non-biological complex drugs

Determining Estrogens Using Surface-Assisted Laser Desorption/Ionization Mass Spectrometry with Silver Nanoparticles as the Matrix

The impact of the rare disease and Orphan Drug Act in Taiwan

Development of the risk-based, phased-in approach for the international harmonization of the regulation of container closure systems for drugs in Taiwan

The evolution and challenges for the international harmonization of the regulation of pharmaceutical excipients in Taiwan

Thyrotropin receptor antibodies and a genetic hint in antithyroid drug-induced adverse drug reactions

Suchergebnisse filtern